e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
427.38
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
601
Open
427.38
Bid (Size)
425.00 (200)
Ask (Size)
430.00 (40)
Prev. Close
427.38
Today's Range
427.38 - 427.38
52wk Range
362.50 - 510.77
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering
↗
April 30, 2026
These companies are leaders in their fields.
Via
The Motley Fool
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
↗
April 30, 2026
The biotech's candidate may treat a great number of illnesses that have one thing in common.
Via
The Motley Fool
Performance
YTD
-5.5%
-5.5%
1 Month
-4.3%
-4.3%
3 Month
-10.2%
-10.2%
6 Month
+1.8%
+1.8%
1 Year
-16.1%
-16.1%
More News
Read More
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
↗
April 30, 2026
Via
The Motley Fool
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth Stock with Promising Technical Setup
↗
April 29, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Growth and Technical Setup
↗
April 03, 2026
Via
Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment
↗
March 28, 2026
Via
Chartmill
3 Growth Stocks That Could Generate 10X Returns
↗
April 29, 2026
Via
The Motley Fool
Topics
Cannabis
Law Enforcement
3 of Wall Street’s Favorite Stocks Worth Your Attention
April 29, 2026
Via
StockStory
3 Market-Beating Stocks to Consider Right Now
April 28, 2026
Via
StockStory
Topics
Energy
3 Healthcare Stocks With the Most Durable Competitive Moats
↗
April 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?
↗
April 21, 2026
Via
The Motley Fool
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term
↗
April 19, 2026
Via
The Motley Fool
Is Vertex Pharmaceuticals' Empire in Trouble?
↗
April 16, 2026
Via
The Motley Fool
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
April 16, 2026
Via
StockStory
Topics
Stocks
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.
↗
April 14, 2026
Via
The Motley Fool
Topics
Economy
Government
Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?
↗
April 07, 2026
Via
The Motley Fool
Topics
ETFs
Vertex to Announce First Quarter 2026 Financial Results on May 4th
April 06, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
April 02, 2026
Via
StockStory
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
April 01, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
March 31, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Stocks
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
March 30, 2026
Via
StockStory
Prediction: The Trump Bull Market Is About to End -- but These Stocks Will Rise Anyway
↗
March 28, 2026
Via
The Motley Fool
Topics
Economy
Energy
Government
2 Stocks I Plan to Hold for the Next 20 Years
↗
March 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
March 27, 2026
Via
StockStory
Where Will Vertex Pharmaceuticals Be in 1 Year?
↗
March 25, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 427.38
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 04/30/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 110.87B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 111B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert